Most Recent
Dairy company Care A2 has settled a dispute with Gensco Laboratories over an agreement to distribute its infant formula in the US that went sour.
The funder bankrolling a class action by residents allegedly displaced by the construction of the $16.8 billion WestConnex tunnel has abandoned the case.
A class action targeting Westpac subsidiary BT Funds and Tal Life Insurance was discontinued after documents discovered by the companies caused funder Woodsford to bow out.
A 'junk' insurance class action against Suncorp unit AAI wants an initial trial to deal with the claim -- absent a sample group member -- that car dealers made purchasing a policy necessary for a loan.
Green iron start-up Element Zero is continuing its fight over search orders won by rival Fortescue that it claimed were a massive over-reach.
The scope of protection for geographical indications will be at issue in India's appeal of a decision that barred it from registering a trade mark for basmati rice.
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
Coles and Woolworths have hit back at the ACCC's claims they advertised “illusory” discounts, pointing the finger at inflation and higher supply costs.
INPEX has won a bid to cross-examine AkzoNobel's solicitors about discovery at the end of an 11-week trial over allegedly defective paint used on the $45 billion Ichthys natural gas project.